A detailed history of Freestone Capital Holdings, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 134,897 shares of ABT stock, worth $15.4 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
134,897
Previous 132,973 1.45%
Holding current value
$15.4 Million
Previous $13.8 Million 11.3%
% of portfolio
0.53%
Previous 0.5%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $192,534 - $227,282
1,924 Added 1.45%
134,897 $15.4 Million
Q2 2024

Nov 22, 2024

BUY
$100.73 - $112.44 $130,344 - $145,497
1,294 Added 0.98%
132,973 $13.8 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $130,344 - $145,497
1,294 Added 0.98%
132,973 $13.8 Million
Q1 2024

Nov 22, 2024

SELL
$109.52 - $120.96 $352,435 - $389,249
-3,218 Reduced 2.39%
131,679 $15 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $440,489 - $486,501
4,022 Added 3.15%
131,679 $15 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $1.3 Million - $1.6 Million
14,464 Added 12.78%
127,657 $14.1 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $58,082 - $69,688
608 Added 0.54%
113,193 $11 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $1.28 Million - $1.43 Million
12,749 Added 12.77%
112,585 $12.3 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $1.09 Million - $1.29 Million
11,303 Added 12.77%
99,836 $10.1 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $285,750 - $335,229
3,006 Added 3.51%
88,533 $9.72 Million
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $1.77 Million - $2.05 Million
-18,292 Reduced 17.62%
85,527 $8.28 Million
Q2 2022

Aug 09, 2022

SELL
$102.07 - $123.37 $1.06 Million - $1.29 Million
-10,420 Reduced 9.12%
103,819 $11.3 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $1.31 Million - $1.6 Million
11,502 Added 11.2%
114,239 $13.5 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $534,441 - $654,393
4,626 Added 4.72%
102,737 $14.5 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $1.94 Million - $2.15 Million
16,627 Added 20.41%
98,111 $11.6 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $440,192 - $518,169
4,161 Added 5.38%
81,484 $9.45 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $460,175 - $542,156
4,228 Added 5.78%
77,323 $9.27 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $2.13 Million - $2.32 Million
20,315 Added 38.49%
73,095 $8 Billion
Q3 2020

Nov 06, 2020

SELL
$91.64 - $111.29 $22,726 - $27,599
-248 Reduced 0.47%
52,780 $5.74 Million
Q2 2020

Aug 04, 2020

SELL
$76.57 - $98.0 $115,926 - $148,372
-1,514 Reduced 2.78%
53,028 $4.85 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $268,995 - $393,344
4,282 Added 8.52%
54,542 $4.3 Million
Q4 2019

Feb 04, 2020

BUY
$78.51 - $87.4 $1.17 Million - $1.3 Million
14,846 Added 41.92%
50,260 $4.37 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $1.32 Million - $1.43 Million
16,149 Added 83.83%
35,414 $2.96 Million
Q2 2019

Aug 05, 2019

SELL
$72.88 - $85.0 $551,774 - $643,535
-7,571 Reduced 28.21%
19,265 $1.62 Million
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $827,154 - $1 Million
-12,491 Reduced 31.76%
26,836 $2.15 Million
Q4 2018

Feb 12, 2019

SELL
$65.56 - $74.27 $227,427 - $257,642
-3,469 Reduced 8.11%
39,327 $2.85 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $165,585 - $199,759
-2,723 Reduced 5.98%
42,796 $3.14 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $26,770 - $29,546
-465 Reduced 1.01%
45,519 $2.78 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $33,762 - $38,172
600 Added 1.32%
45,984 $2.76 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $28,718 - $30,746
535 Added 1.19%
45,384 $2.59 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $63,391 - $70,751
1,319 Added 3.03%
44,849 $2.39 Million
Q2 2017

Aug 15, 2017

BUY
N/A
43,530
43,530 $2.12 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.